Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Isomalto-Oligosaccharide market in this environment.
In terms of revenue, this research report indicated that the global Isomalto-Oligosaccharide market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Isomalto-Oligosaccharide industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Meiji Co., Ltd. aims at producing XX Isomalto-Oligosaccharide in 2020, with XX % production to take place in global market, ? ? BioNeutra accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Isomalto-Oligosaccharide Market by XYZResearch Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Isomalto-Oligosaccharide Market?
Meiji Co., Ltd.
BioNeutra
Baolingbao Biology
Shandong Tianmei
WELLCHEN
New Francisco Biotechnology Corporation (NFBC)
Dancheng Caixin
Caixin
Fullsail
...
Major Type of Isomalto-Oligosaccharide Covered in XYZResearch report:
Natural
Synthetic
Application Segments Covered in XYZResearch Market
Drink
Dairy Products
Cold Drink
Baked Food
Other
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Isomalto-Oligosaccharide Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Natural -Product Introduction and Major Manufacturers
1.1.2 Synthetic -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Isomalto-Oligosaccharide Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis
3.1 China Isomalto-Oligosaccharide Market
3.1.1 Top Companies leading Isomalto-Oligosaccharide Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Isomalto-Oligosaccharide Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)
3.2 EU Isomalto-Oligosaccharide Market
3.2.1 Top Companies leading Isomalto-Oligosaccharide Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Isomalto-Oligosaccharide Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)
3.3 USA Isomalto-Oligosaccharide Market
3.3.1 Top Companies leading Isomalto-Oligosaccharide Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Isomalto-Oligosaccharide Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)
3.4 Japan Isomalto-Oligosaccharide Market
3.4.1 Top Companies leading Isomalto-Oligosaccharide Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Isomalto-Oligosaccharide Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)
3.5 India Isomalto-Oligosaccharide Market
3.5.1 Top Companies leading Isomalto-Oligosaccharide Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Isomalto-Oligosaccharide Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)
3.6 Southeast Asia Isomalto-Oligosaccharide Market
3.6.1 Top Companies leading Isomalto-Oligosaccharide Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Isomalto-Oligosaccharide Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Isomalto-Oligosaccharide Market
3.7.1 Top Companies leading Isomalto-Oligosaccharide Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Isomalto-Oligosaccharide Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)
4.1 Isomalto-Oligosaccharide Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Isomalto-Oligosaccharide Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2026)
5.1 Global Isomalto-Oligosaccharide Sales and Growth Rate (2021-2026)
5.2 Global Isomalto-Oligosaccharide Sales Value and Growth Rate (2021-2026)
6 Isomalto-Oligosaccharide Competitive Analysis
6.1 Meiji Co., Ltd.
6.1.1 Meiji Co., Ltd. Company Profiles
6.1.2 Meiji Co., Ltd. Product Introduction
6.1.3 Meiji Co., Ltd. Isomalto-Oligosaccharide Production, Revenue (2015-2020)
6.1.4 SWOT Analysis
6.2 BioNeutra
6.2.1 BioNeutra Company Profiles
6.2.2 BioNeutra Product Introduction
6.2.3 BioNeutra Isomalto-Oligosaccharide Production, Revenue (2015-2020)
6.2.4 SWOT Analysis
6.3 Baolingbao Biology
6.3.1 Baolingbao Biology Company Profiles
6.3.2 Baolingbao Biology Product Introduction
6.3.3 Baolingbao Biology Isomalto-Oligosaccharide Production, Revenue (2015-2020)
6.3.4 SWOT Analysis
6.4 Shandong Tianmei
6.4.1 Shandong Tianmei Company Profiles
6.4.2 Shandong Tianmei Product Introduction
6.4.3 Shandong Tianmei Isomalto-Oligosaccharide Production, Revenue (2015-2020)
6.4.4 SWOT Analysis
6.5 WELLCHEN
6.5.1 WELLCHEN Company Profiles
6.5.2 WELLCHEN Product Introduction
6.5.3 WELLCHEN Isomalto-Oligosaccharide Production, Revenue (2015-2020)
6.5.4 SWOT Analysis
6.6 New Francisco Biotechnology Corporation (NFBC)
6.6.1 New Francisco Biotechnology Corporation (NFBC) Company Profiles
6.6.2 New Francisco Biotechnology Corporation (NFBC) Product Introduction
6.6.3 New Francisco Biotechnology Corporation (NFBC) Isomalto-Oligosaccharide Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 Dancheng Caixin
6.7.1 Dancheng Caixin Company Profiles
6.7.2 Dancheng Caixin Product Introduction
6.7.3 Dancheng Caixin Isomalto-Oligosaccharide Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
6.8 Caixin
6.8.1 Caixin Company Profiles
6.8.2 Caixin Product Introduction
6.8.3 Caixin Isomalto-Oligosaccharide Production, Revenue (2015-2020)
6.8.4 SWOT Analysis
6.9 Fullsail
6.9.1 Fullsail Company Profiles
6.9.2 Fullsail Product Introduction
6.9.3 Fullsail Isomalto-Oligosaccharide Production, Revenue (2015-2020)
6.9.4 SWOT Analysis
7 Conclusion